https://doi.org/10.4081/monaldi.2022.2371

Mycobacterium kansasaii and Mycobacterium scrofulaceum dual pulmonary infection in an immunocompetent male: first report from India

Vol. 93 No. 3 (2023)
Submitted: July 6, 2022
Accepted: October 18, 2022
Published: November 2, 2022
acid fast bacilli, nontuberculous mycobacteria, pulmonary tuberculosis, mixed NTM infection
Abstract Views: 733
PDF: 156
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Ranganath T. Ganga
ranganathtg@gmail.com
https://orcid.org/0000-0003-1790-747X
Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Pratibha Sharma
Department of Microbiology, Sri Balaji Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Saroj K. Pati
Department of Radiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Ajoy K. Behera
Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.
Sunil K. Reddy
NTEP Unit Department of Pulmonary Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India.

A 57-year-old farmer presented with chronic cough and recurrent hemoptysis, previously treated for sputum positive pulmonary tuberculosis. Referred to us for evaluation of drug resistant tuberculosis as his sputum was persistently positive for acid fast bacilli along with radiological worsening even after 6 months of antitubercular treatment. Bronchoalveolar lavage was done and he was diagnosed with a rare mixed non-tuberculous mycobacyteria (NTM) pulmonary infection despite no immune dysfunction. He was successfully treated with multidrug regimen of rifampicin, isoniazid, ethambutol and clarithromycin.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Porvaznik I, Solovič I, Mokrý J. Non-tuberculous mycobacteria: Classification, diagnostics, and therapy. Adv Exp Med Biol 2017;944:19-25. DOI: https://doi.org/10.1007/5584_2016_45
Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med 2015;36:1-11. DOI: https://doi.org/10.1016/j.ccm.2014.10.001
Gonzalez-Santiago TM, Drage LA. Nontuberculous mycobacteria: Skin and soft tissue infections. Dermatol Clin 2015;33:563-77. DOI: https://doi.org/10.1016/j.det.2015.03.017
van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med 2015;36:43-54. DOI: https://doi.org/10.1016/j.ccm.2014.11.005
Jani MN, Rodrigues CS, Mehta AP. The neglected and often ignored: nontuberculous mycobacteria. J Glob Infect Dis 2011;3:94. DOI: https://doi.org/10.4103/0974-777X.77305
Sharma SK, Upadhyay V. Non-tuberculous mycobacteria: a disease beyond TB and preparedness in India. Expert Rev Respir Med 2021;15:949-58. DOI: https://doi.org/10.1080/17476348.2021.1925545
Jain S, Sankar MM, Sharma N, et al. High prevalence of non-tuberculous mycobacterial disease among non-HIV infected individuals in a TB endemic country--experience from a tertiary center in Delhi, India. Pathog Glob Health 2014;108:118-22. DOI: https://doi.org/10.1179/2047773214Y.0000000133
Shin SH, Jhun BW, Kim SY, et al. Nontuberculous mycobacterial lung diseases caused by mixed infection with Mycobacterium avium complex and Mycobacterium abscessus complex. Antimicrob Agents Chemother 2018;62:e01105-18. DOI: https://doi.org/10.1128/AAC.01105-18
Kurahara Y, Tachibana K, Tsuyuguchi K, Suzuki K. Mixed pulmonary infection with three types of nontuberculous mycobacteria. Intern Med. 2013;52:507-10. DOI: https://doi.org/10.2169/internalmedicine.52.8907
Singh AK, Marak RS, Maurya AK, et al. Mixed cutaneous infection caused by Mycobacterium szulgai and Mycobacterium intermedium in a healthy adult female: a rare case report. Case Rep Dermatol Med 2015;2015:607519. DOI: https://doi.org/10.1155/2015/607519
DeStefano MS, Shoen CM, Cynamon MH. Therapy for Mycobacterium kansasii infection: beyond 2018. Front Microbiol 2018;9:2271. DOI: https://doi.org/10.3389/fmicb.2018.02271

How to Cite

Ganga, Ranganath T., Pratibha Sharma, Saroj K. Pati, Ajoy K. Behera, and Sunil K. Reddy. 2022. “<em>Mycobacterium kansasaii</em> and <em>Mycobacterium scrofulaceum</em> Dual Pulmonary Infection in an Immunocompetent Male: First Report from India”. Monaldi Archives for Chest Disease 93 (3). https://doi.org/10.4081/monaldi.2022.2371.
Copyright (c) 2022 The Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.